ArticleOncotarget2018

Targeting the Golgi apparatus to overcome acquired resistance of non-small cell lung cancer cells to EGFR tyrosine kinase inhibitors.

Yoshimi Ohashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.